Bristol Myers Squibb (BMS) and AstraZeneca are reportedly considering a merger that could create a company valued at nearly $400 billion.
The companies are among the largest pharmaceutical employers in...
It’s a given. Few people relish the prospect of public speaking in general. Add a couple of unfortunate circumstances, and the fear becomes positively...